SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chiplun Fine Chemicals Ltd (530417) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 530417 NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Chiplun Fine Chemicals Ltd (530417)

BSE: 530417 NSE:
Key Metrics
Market Cap
₹2 Cr.
P/E Ratio
0.00
Price to Book (P/B)
0.50
Price to Sales (P/S)
0.96
EV/EBITDA
8.20
Return on Capital Employed (ROCE)
4.79%
Current Price
₹0
Return on Equity (ROE)
0.01%
Return on Assets (ROA)
0.00%
Operating Profit Margin
-9.1%
Net Profit Margin
0.01%
Gross Profit Margin
12.4%
Book Value per Share
₹6
Sales Growth (YoY)
-10.27%
Sales Growth (3 Years)
-0.42%
Operating Profit Growth (1 Year)
NA%
Operating Profit Growth (3 Years)
N/A%
Net Profit Growth (1 Year)
NA%
52-Week Low / High
₹0 / 0
Net Profit Growth (3 Years)
N/A%
Dividend Yield
0.00%
Promoter Holding
%
Pledged shares (%)
of Promoter's holding (%)
%

DeciZen - make an informed investing decision on Chiplun Fine Chem

Based on:

M-Cap below 100cr DeciZen not available

Chiplun Fine Chemicals stock performance

Key Ratios
mw4me loader

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'98Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04TTM
ROCE % -0.1%-3.9%-4.9%-4.3%-4.3%3.7%4.8%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3.32.82.52.422.62.42
Sales YoY Gr.--14.3%-11%-4.8%-18.4%34.9%-10.3%-
Adj EPS -0.4-0.8-0.7-0.8-0.6-0-00
YoY Gr.-NANANANANANA-
BVPS (₹) 8.17.77.16.45.85.76.66
Adj Net
Profit
-0.3-0.6-0.5-0.6-0.5-0-00
Cash Flow from Ops. 00.30.2-0.1-00.4-1.2-
Debt/CF from Ops. 37.63.95.8-18.7-46.33.1-2.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-3.5%-0.4%-10.3%
Adj EPS NANANANA
BVPSNA-3.1%0.7%14.7%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'98Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04TTM
Return on
Equity %
-4.9-8.8-9-10.3-9.6-0-0.10
Op. Profit
Mgn %
-5.9-8.3-10.1-16.2-34.20.1-9.1-9.2
Net Profit
Mgn %
-10.1-20.5-21.7-23.9-24.7-0-0.20
Debt to
Equity
0.20.20.20.30.40.30.6-
Working Cap
Days
06587557719768661,1840
Cash Conv.
Cycle
03413603765393284660

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 2.4 -
BVPS (₹) 6 -
Reserves (₹ Cr.) -2 -
P/BV 0.50 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 0.25 / 22.00
Market Cap (₹ Cr.) 2.3
Equity (₹ Cr.) 7.5
Face Value (₹) 10
Industry PE 42.1

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Chiplun Fine Chem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04
Sales3.292.822.512.391.952.632.36
Operating Expenses + 3.483.062.762.772.622.632.57
Manufacturing Costs0.560.520.520.680.770.580.80
Material Costs2.311.911.661.391.141.220.84
Employee Cost 0.230.260.270.280.320.350.47
Other Costs 0.380.360.310.420.400.480.46
Operating Profit -0.19-0.24-0.25-0.39-0.670-0.21
Operating Profit Margin (%) -5.9%-8.4%-10.1%-16.2%-34.2%0.1%-9.1%
Other Income + 0.380.190.160.350.650.470.83
Exceptional Items 0000000
Interest 0.320.220.220.270.210.220.33
Depreciation 0.200.220.230.240.250.260.29
Profit Before Tax -0.32-0.49-0.54-0.54-0.4800
Tax 0000000
Profit After Tax -0.32-0.49-0.54-0.54-0.4800
PAT Margin (%) -9.9%-17.4%-21.6%-22.8%-24.6%0.1%0.0%
Adjusted EPS (₹)-0.4-0.7-0.7-0.7-0.60.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04

Equity and Liabilities

Shareholders Fund + 6.826.335.785.244.804.805.57
Share Capital 7.547.547.547.547.547.547.54
Reserves -0.72-1.21-1.75-2.30-2.74-2.74-1.97
Debt +1.041.011.151.381.761.233.14
Long Term Debt1.041.011.151.381.761.233.14
Short Term Debt0000000
Minority Interest0000000
Trade Payables1.201.511.821.372.043.623.41
Others Liabilities 0.140.130.300.310.560.730.19
Total Liabilities 9.208.989.068.319.1610.3912.30

Fixed Assets

Net Fixed Assets +2.332.142.141.981.851.772.09
Gross Block3.233.273.493.573.693.874.48
Accumulated Depreciation0.911.121.351.591.842.102.39
CWIP 0.890.890.800.800.800.800.80
Investments 0.010.010.010.010.010.010.01
Inventories1.921.771.811.822.2633.87
Trade Receivables1.962.082.221.822.232.702.72
Cash Equivalents 0.150.320.350.350.420.480.33
Others Assets 1.951.771.741.541.591.642.48
Total Assets 9.208.989.068.319.1610.3912.30

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04
Cash Flow From Operating Activity + 0.030.260.20-0.07-0.040.40-1.24
PBT -0.32-0.49-0.54-0.54-0.4800
Adjustment 0.460.590.600.630.570.590.66
Changes in Working Capital 0.20.360.170.06-0.14-0.19-2.01
Tax Paid 0000000
Cash Flow From Investing Activity + 0.02-0.04-0.30-0.17-0.27-0.37-0.81
Capex -0.15-0.04-0.22-0.08-0.12-0.18-0.62
Net Investments 0000000
Others 0.170-0.08-0.08-0.15-0.20-0.19
Cash Flow From Financing Activity + -0.14-0.060.140.240.380.031.90
Net Proceeds from Shares 0000000
Net Proceeds from Borrowing -0.07-0.050-0.03-0.170.031.90
Interest Paid 0000000
Dividend Paid 0000000
Others -0.07-0.010.140.260.5500
Net Cash Flow -0.100.170.04-00.070.06-0.15

Finance Ratio

PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04
Ratios
ROE (%)-5.32-8.27-9.76-10.71-10.420.050.01
ROCE (%)-0.12-3.85-4.87-4.33-4.333.734.79
Asset Turnover Ratio0.360.310.280.270.220.270.21
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days218261313309380342420
Inventory Days213239261277382364532
Payable Days1902603684205488491,536

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Chiplun Fine Chemicals Ltd FAQs

The current trading price of Chiplun Fine Chem on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Chiplun Fine Chem stood at ₹2.26 Cr

The latest P/E ratio of Chiplun Fine Chem as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Chiplun Fine Chem as of 31-Dec-1969 is 0.50.

The 52-week high of Chiplun Fine Chem is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chiplun Fine Chem is ₹2.36 ( Cr.) .

About Chiplun Fine Chemicals Ltd

Chiplun Fine Chemicals was originally incorporated as a Private Limited Company on February 25, 1982, under the name of Chiplun Fine Chemicals Private Ltd. Subsequently, the company was converted into a Public Limited Company pursuant to a Special Resolution passed by the members at its Extra Ordinary General Meeting held on August 18th, 1992. The Company received a Certificate of Change of Name from the Registrar of Companies, Maharashtra on March 23, 1993.The company came out with a public issue in March 1995. In 1995-96, the company entered the US market for exporting one of its products for which it received firm order indicating the annual requirement.

Business of the company:

The company was incorporated to purchase, sell, import, export, deal in wholesale and retail, supply, exchange, distribute, redistribute, process pack, store, size  and manufacture Fine Chemicals.

The Company is presently engaged in the manufacture of DRUG IBUPROFEN at an installed capacity of 90 TPA. The company at its plant located at Lote Parshuram manufactures bulk drug ibuprofen with an installed capacity of 90 tpa.

Some of the important customers of the company are Aristo Pharmaceuticals, Cachet Pharmaceutical Pvt Ltd, Alkem, Hindustan Tablets, Galfa Laboratories, etc.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×